- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07573540
Optimizing Smart Technology for Addiction Recovery (STAR)
22. juni 2026 opdateret af: University of Wisconsin, Madison
Optimizing Algorithmic Feedback About Lapse Risk for Trust, Engagement, and Clinical Outcomes for Alcohol Use Disorder
The goal of this study is to develop a machine-learning guided recovery messaging system. The main question it aims to answer is can messages be used to:
- help people to improve their health
- make changes in people's lives to address alcohol and substance use
Participants will:
- complete surveys
- use a recovery-support digital therapeutic system
Studieoversigt
Status
Rekruttering
Intervention / Behandling
Detaljeret beskrivelse
This study seeks to optimize messaging components which can be implemented in a recovery support messaging system such as may accompany a digital therapeutic app, in order to determine optimal messaging to increase interaction with recovery support resources, and whether messaging has any effect on clinical outcomes.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
416
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Susan Wanta
- Telefonnummer: 608-262-0387
- E-mail: schneck2@wisc.edu
Undersøgelse Kontakt Backup
- Navn: Thea Blum
- Telefonnummer: 608-262-1362
- E-mail: tblm4@wisc.edu
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53706
- Rekruttering
- University of Wisconsin
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- meet criteria for alcohol use disorder with at least moderate severity (>= 4 DSM-5 criteria)
- in initial remission with most recent use of alcohol between 1 week and 3 months in the past
- able to read English
- have a smartphone and cellular plan that supports STAR use (Apple iOS or Android)
Exclusion Criteria:
- medical or psychiatric co-morbidities that preclude use of a smartphone
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: STAR
Participants will use the STAR automated recover support system for 4 months
|
Automated recovery support messaging system for participants with alcohol use disorder (AUD), paired with a machine learning guided relapse risk prediction model.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Participant engagement with the STAR system
Tidsramme: data collected at 2 and 4 months
|
Measured as days of engagement with the recovery system.
|
data collected at 2 and 4 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of heavy drinking days in the previous 28 days
Tidsramme: data collected at baseline, 2, 4 months
|
Data collected via Timeline Followback (TLFB) conducted by interview at 0, 2, and 4 months.
Ecological Momentary Assessment (EMA) lapse reports will be used to supplement the TLFB.
These are daily surveys where the participant answers the question "have you had a drink you have not yet reported?"
(Yes/No).
If yes they are asked to indicate the date of their drinking and how many drinks they consumed that day (less than 1, 1-2, 3, 4, 5-6, 7-8, over 8).
Four or more drinks are considered heavy drinking days for women and greater than 4 drinks are considered heavy drinking days for men.
|
data collected at baseline, 2, 4 months
|
|
Number of drinking days in the previous 28 days
Tidsramme: data collected at baseline, 2, 4 months
|
Data collected via Timeline Followback (TLFB) conducted by interview at 0, 2, and 4 months.
EMA lapse reports will be used to supplement the TLFB.
These are daily surveys where the participant answers the question "have you had a drink you have not yet reported?"
(Yes/No).
If yes, they are asked to indicate the date of their drinking.
|
data collected at baseline, 2, 4 months
|
|
Flourishing Scale Score
Tidsramme: data collected at baseline, 2, 4 months
|
10 items rated on 0-10 Likert scale where lower scores represent worse functioning and higher scores represent better functioning.
Total possible range of scores is from 0-100.
|
data collected at baseline, 2, 4 months
|
|
Generalized Anxiety Disorder-7 (GAD-7) Score
Tidsramme: data collected at baseline, 2, 4 months
|
7 items rated on 0-3 Likert scale where lower scores represent better functioning and higher scores represent worse functioning.
Total possible range of scores is from 0-21.
|
data collected at baseline, 2, 4 months
|
|
Multidimensional Inventory of Recovery Capital (MIRC) Score: Total Score
Tidsramme: data collected at baseline, 2, 4 months
|
1-4 Likert scale.
Some items are reverse coded but higher total scores represent better functioning and lower total scores represent worse functioning.
Scored as total score 4-56.
|
data collected at baseline, 2, 4 months
|
|
Multidimensional Inventory of Recovery Capital (MIRC) Score: Each Domain
Tidsramme: data collected at baseline, 2, 4 months
|
1-4 Likert scale.
Some items are reverse coded but higher total scores represent better functioning and lower total scores represent worse functioning.
Scored in 4 domains (social, physical, human, and cultural), each from 1-14.
|
data collected at baseline, 2, 4 months
|
|
Patient Health Questionnaire (PQH-9) Score
Tidsramme: data collected at baseline, 2, 4 months
|
9 items rated on 1-4 Likert scale.
Total possible range of scores from 0-27 where lower scores represent better functioning and higher scores represent worse functioning.
|
data collected at baseline, 2, 4 months
|
|
Digital Working Alliance Inventory (D-WAI)
Tidsramme: data collected at 2 and 4 months
|
Six items rated on 1-7 Likert scale.
Scored in 3 domains (Goals, Tasks, Bonds, each with 2 items) with possible scores from 2 to 14 where higher scores represent greater alliance with the STAR system in that domain.
|
data collected at 2 and 4 months
|
|
Message Usefulness
Tidsramme: data collected at 2 and 4 months
|
Seven items rated on 1-7 Likert scale.
Total possible scores from 7 to 49 where higher scores represent greater valuation of STAR message usefulness.
|
data collected at 2 and 4 months
|
|
Trust of the System
Tidsramme: data collected at 2 and 4 months
|
Ten items rated on 1-7 Likert scale.
Total possible scores from 10 to 70 where higher scores represent greater trust in the STAR system.
|
data collected at 2 and 4 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: John Curtin, PhD, University of Wisconsin, Madison
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
24. september 2025
Primær færdiggørelse (Anslået)
31. januar 2029
Studieafslutning (Anslået)
31. juli 2029
Datoer for studieregistrering
Først indsendt
30. april 2026
Først indsendt, der opfyldte QC-kriterier
30. april 2026
Først opslået (Faktiske)
7. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
25. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2024-0869
- A487400 (Anden identifikator: UW Madison)
- 1R01AA031762-01 (U.S. NIH-bevilling/kontrakt)
- Protocol Version 4/22/2026 (Anden identifikator: UW Madison)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .